Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by BearDownAZ

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:Sangamo and Hunter Syndrome

Furthermore, one of the most developed preclinical programs at biOasis is for...

November 18, 2017

V.BTI.H

RE:RE:RE:RE:Sangamo and Hunter Syndrome

And before anyone calls me out on it........I mistakenly referred to Sangamo...

November 17, 2017

V.BTI.H

RE:RE:RE:RE:Sangamo and Hunter Syndrome

Here's a link to Sangamo's 2015 publication "In vivo genome...

November 17, 2017

V.BTI.H

RE:RE:RE:Sangamo and Hunter Syndrome

JD, Yes, I think you are probably right that Sangamo chose this MPS II...

November 17, 2017

V.BTI.H

RE:Sangamo and Hunter Syndrome

Very interesting JD. Thanks for sharing. BDAZ

November 16, 2017

V.BTI.H

RE:Met with Mark Day and Catherine London today

LCP7777, I had the pleasure of meeting Mark and Catherine as well (last month...

November 8, 2017

ESPR

Franchise Development Program Updates; Q3 2017 Financials

Esperion Provides Bempedoic Acid Franchise Development Program Updates...

November 7, 2017

ESPR

Initiation of Pivotal Phase 3 Study for BA/Ezetimibe Combo

Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid...

November 6, 2017

V.BTI.H

RE:RE:Transend/ JUNO?? DIFFERENT TRANSEND?

TRANSCEND is just the name of the clinical trial that has no relation to BTI...

November 1, 2017

V.BTI.H

RE:Is it just me?

No, it is not just you.

October 30, 2017

ESPR

RE:Esperion to Host Analyst and Investor Day Event October 17

In case you missed it, the Investor Day presentation from Oct 17, 2017 will...

October 26, 2017

V.BTI.H

RE:RE:RE:RE:RE:Phase 0

Digitel, You quoted this statement from the June News Release "The...

October 22, 2017

V.BTI.H

RE:RE:6 months

Mark Day has taken control. Surrounding himself with amazing talent...

October 20, 2017

ESPR

Esperion to Host Analyst and Investor Day Event October 17

Get your popcorn ready...... Esperion to Host Analyst and Investor Day...

October 10, 2017

V.BTI.H

RE:RE:RE:Where the heck?

That is an amazing new website. Great job team biOasis! The BBB and platform...

October 9, 2017

T.RVX

RE:RE:Did the goalpost just get moved?

"To our resident guru Bear, what would kicking the can down the road to...

September 14, 2017

V.BTI.H

RE:RE: proprietary xB3 BBB drug delivery tech

JD, Thanks for the thorough explanation of the new "xB3"...

September 7, 2017

V.BTI.H

RE: proprietary xB3 BBB drug delivery tech

I'm assuming that the xB3 BBB technology includes Mtfp. However, this...

September 7, 2017

T.RVX

RE:RE:CETP NOT HELPFUL IN. DIABETES

Ronrydell, A somewhat vague post and much of this is old news. CETP...

September 3, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Question on FA timing? Bear?

I incorrectly wrote in the last paragraph that I still see us on track to hit...

September 2, 2017

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation V.HFM